Defining the minimal important change and meaningful change value of the disease activity index for psoriatic arthritis: a Chinese longitudinal study
CONCLUSION: MIC, offering physicians an additional means to contextualize the patient's perception of disease activity during treatment, and a change of 10.5 is likely to be regarded as a clinically meaningful change, enhancing the utility of DAPSA in PsA clinical trials.PMID:38490673 | DOI:10.3899/jrheum.2023-1085
Source: J Rheumatol - Category: Rheumatology Authors: Yijie Liu Minjia Tan Kun Hu SiChun Deng Lu Jian Junchen Chen Mi Zhang Yehong Kuang Source Type: research
More News: Arthritis | China Health | Clinical Trials | Dermatology | Psoriatic Arthritis | Rheumatology | Skin | Study